12:00 AM
 | 
Jun 03, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Altor BioScience preclinical data

In a mouse model of MM, a single IV dose of ALT-803 significantly reduced the percentage of cells of 2 MM cell lines in bone marrow vs....

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >